Skip to content
The Policy VaultThe Policy Vault

GrastekMedica

grass pollen-induced allergic rhinitis

Initial criteria

  • age ≥ 5 years
  • Therapy timing meets ONE of the following (i or ii): i) Grastek therapy initiated 12 weeks prior to the expected onset of the grass pollen season OR dosed daily continuously for consecutive grass pollen seasons; OR ii) Oralair therapy initiated 4 months prior to the expected onset of the grass pollen season
  • Diagnosis confirmed by ONE of the following (i or ii): i) positive skin test response to a grass pollen from the Pooideae subfamily of grasses (e.g., sweet vernal, Kentucky blue grass, Timothy grass, orchard, or perennial rye grass); OR ii) positive in vitro test for allergen-specific immunoglobulin E antibodies for a grass in the Pooideae subfamily of grasses

Approval duration

1 year